In the PIONEER-HF study conducted in patients hospitalized for acute HF, treatment with sacubitril/valsartan produced a 29% greater reduction in the NT-proBNP plasma concentration compared with enalapril (percent change, −46.7% vs. −25.3%), without significant differences in the risk of adverse events. Here, NPPB is linked to hydrops fetalis.